InsiderCEO
Bobak R. Azamian Insider Trading Activity
Every SEC Form 4 transaction reported by Bobak R. Azamian, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Is Bobak R. Azamian buying or selling?
Bobak R. Azamian reported 0 open-market buys ($0) and 51 sells ($12.9M) across 51 Form 4 filings at 1 company — a net selling position of $12.9M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 22, 2026)
Total Form 4 filings
51
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (51)
$12.9M
Insider sentiment
Net sellingNet insider flow of $12.9M in net selling, filed between Aug 6, 2021 – Jun 22, 2026.
Companies Bobak R. Azamian files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | TARSTarsus Pharmaceuticals, Inc. | 51 |
Recent Bobak R. Azamian transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | TARS | President/CEO and Board Chair | Sale | 10.0K | $615.5K |
| Mar 19, 2026 | TARS | President/CEO and Board Chair | Sale | 34.6K | $2.4M |
| Dec 30, 2025 | TARS | President/CEO and Board Chair | Sale | 6.0K | $495.1K |
| Sep 26, 2025 | TARS | President/CEO and Board Chair | Sale | 6.0K | $332.2K |
| Aug 13, 2025 | TARS | President/CEO and Board Chair | Sale | 6.0K | $300.0K |
| Mar 26, 2025 | TARS | President/CEO and Board Chair | Sale | 6.0K | $300.0K |
| Mar 21, 2025 | TARS | President/CEO and Board Chair | Sale | 24.2K | $1.2M |
| Dec 29, 2023 | TARS | President/CEO and Board Chair | Sale | 8.0K | $161.8K |
| Dec 22, 2023 | TARS | President/CEO and Board Chair | Sale | 40.0K | $810.6K |
| Nov 17, 2023 | TARS | President/CEO and Board Chair | Sale | 8.0K | $146.9K |
| Oct 20, 2023 | TARS | President/CEO and Board Chair | Sale | 8.0K | $105.9K |
| Sep 22, 2023 | TARS | President/CEO and Board Chair | Sale | 8.0K | $137.7K |
| Aug 25, 2023 | TARS | President/CEO and Board Chair | Sale | 8.0K | $137.8K |
| Jul 21, 2023 | TARS | President/CEO and Board Chair | Sale | 103.9K | $2.1M |
| Jul 14, 2023 | TARS | President/CEO and Board Chair | Sale | 9.0K | $156.2K |
| Jun 23, 2023 | TARS | President/CEO and Board Chair | Sale | 8.0K | $149.0K |
| Jun 16, 2023 | TARS | President/CEO and Board Chair | Sale | 9.0K | $167.2K |
| Jun 12, 2023 | TARS | President/CEO and Board Chair | Sale | 3.1K | $62.0K |
| May 19, 2023 | TARS | President/CEO and Board Chair | Sale | 8.0K | $127.2K |
| May 12, 2023 | TARS | President/CEO and Board Chair | Sale | 9.0K | $151.2K |
| May 2, 2023 | TARS | President/CEO and Board Chair | Sale | 10.1K | $152.9K |
| Apr 25, 2023 | TARS | President/CEO and Board Chair | Sale | 2.3K | $34.7K |
| Apr 21, 2023 | TARS | President/CEO and Board Chair | Sale | 8.0K | $108.8K |
| Mar 23, 2023 | TARS | President/CEO and Board Chair | Sale | 2.1K | $26.7K |
| Mar 21, 2023 | TARS | President/CEO and Board Chair | Sale | 1.5K | $19.9K |
Showing the 25 most recent filings of 51. Screen every filing.
Bobak R. Azamian insider trading FAQ
Is Bobak R. Azamian buying or selling?
Across 51 SEC Form 4 filings, Bobak R. Azamian reported 0 open-market purchases totaling $0 and 51 sales totaling $12.9M — a net selling position of $12.9M.
Which companies does Bobak R. Azamian file Form 4s for?
Bobak R. Azamian has reported insider transactions at 1 company, most often Tarsus Pharmaceuticals, Inc. (TARS).
How far back does Bobak R. Azamian's filing history go?
Trabud holds Bobak R. Azamian's SEC Form 4 filings from Aug 6, 2021 – Jun 22, 2026, sourced directly from SEC EDGAR.
Where does Trabud get Bobak R. Azamian's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Bobak R. Azamian and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener